Michael Magers

All filings by Michael Magers on record concern Gene Biotherapeutics, Inc. The record holds 2 filings, for trades running from 11 April 2007 to 31 October 2007.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 2 November 2007, the filings show a transaction in Gene Biotherapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.